337
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Long-Circulating Lipid Nanospheres Loaded with Flurbiprofen Axetil for Targeted Rheumatoid Arthritis Treatment

, , , , , , , ORCID Icon, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 5159-5181 | Received 17 May 2023, Accepted 09 Aug 2023, Published online: 08 Sep 2023

References

  • Ptacek J, Hawtin RE, Sun D, et al. Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity. PLoS One. 2021;16:1. doi:10.1371/journal.pone.0244187
  • Tanaka Y, Hoshino-Negishi K, Kuboi Y, et al. Emerging role of fractalkine in the treatment of rheumatic diseases. Immunotargets Ther. 2020;9:241–253. doi:10.2147/itt.S277991
  • Ye Z, Shen Y, Jin K, et al. Arachidonic acid-regulated calcium signaling in T cells from patients with rheumatoid arthritis promotes synovial inflammation. Nat Commun. 2021;12(1):907. doi:10.1038/s41467-021-21242-z
  • Yang M, Feng X, Ding J, et al. Nanotherapeutics relieve rheumatoid arthritis. J Control Release. 2017;252:108–124. doi:10.1016/j.jconrel.2017.02.032
  • Gunasekera WM, Kirwan JR. Rheumatoid arthritis: previously untreated early disease. BMJ Clin Evid. 2016;2016:1.
  • Wei W, Lu W, Chen X, et al. Use of network pharmacology to investigate the mechanism of the compound xuanju capsule in the treatment of rheumatoid arthritis. Biomed Res Int. 2021;2021:1–14. doi:10.1155/2021/5568791
  • Feldmann M, Maini RN. Perspectives from masters in rheumatology and autoimmunity: can we get closer to a cure for rheumatoid arthritis? Arthritis Rheumatol. 2015;67(9):2283–2291. doi:10.1002/art.39269
  • Arfè A, Scotti L, Varas-Lorenzo C, et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 2016;354. doi:10.1136/bmj.i4857
  • Qiu S, Wu X, Li Z, et al. A smart nanoreactor based on an O2-economized dual energy inhibition strategy armed with dual multi-stimuli-responsive “Doorkeepers” for Enhanced CDT/PTT of rheumatoid arthritis. ACS Nano. 2022;16(10):17062–17079. doi:10.1021/acsnano.2c07338
  • Qiu S, Wu X, Geng D, et al. H2O2/NIR-sensitive “two-step” nano theranostic system based hollow mesoporous copper sulfide/hyaluronic acid/JWH133 as an optimally designed delivery system for multidimensional treatment of RA. Int J Biol Macromol. 2023;225:298–309. doi:10.1016/j.ijbiomac.2022.11.019
  • Yuan F, Quan LD, Cui L, et al. Development of macromolecular prodrug for rheumatoid arthritis. Adv Drug Deliv Rev. 2012;64(12):1205–1219. doi:10.1016/j.addr.2012.03.006
  • Zhao M, Liu M. New avenues for nanoparticle-related therapies. Nanoscale Res Lett. 2018;13(1):136. doi:10.1186/s11671-018-2548-8
  • Zhou M, Hou J, Zhong Z, et al. Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy. Drug Deliv. 2018;25(1):716–722. doi:10.1080/10717544.2018.1447050
  • Liu S. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Mol Pharm. 2006;3(5):472–487. doi:10.1021/mp060049x
  • Wilder RL. Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis. 2002;61(2):96ii–99. doi:10.1136/ard.61.suppl_2.ii96
  • Liu W, Zhang Y, Zhu W, et al. Sinomenine inhibits the progression of rheumatoid arthritis by regulating the secretion of inflammatory cytokines and monocyte/macrophage subsets. Front Immunol. 2018;9:2228. doi:10.3389/fimmu.2018.02228
  • Emam SH, Sonousi A, Osman EO, et al. Design and synthesis of methoxyphenyl- and coumarin-based chalcone derivatives as anti-inflammatory agents by inhibition of NO production and down-regulation of NF-κB in LPS-induced RAW264.7 macrophage cells. Bioorg Chem. 2021;107:104630. doi:10.1016/j.bioorg.2021.104630
  • Matsumoto T, Takahashi N, Kojima T, et al. Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophages. Arthritis Res Ther. 2016;18(1):133. doi:10.1186/s13075-016-1035-9
  • Fu S, Xu X, Ma Y, et al. RGD peptide-based non-viral gene delivery vectors targeting integrin α v β 3 for cancer therapy. J Drug Target. 2019;27(1):1–11. doi:10.1080/1061186x.2018.1455841
  • Lomen PL, Lamborn KR, Porter GH, et al. Treatment of osteoarthritis of the knee. A comparison of flurbiprofen and aspirin. Am J Med. 1986;80(3a):97–102. doi:10.1016/0002-9343(86)90122-1
  • Zhao X, Ji L. Flurbiprofen axetil: analgesic effect and adverse reaction. Pak J Pharm Sci. 2018;31:1163–1167.
  • Zhang J, Zhang H, Zhao L, Gu J, Feng Y, An H. Erratum: population pharmacokinetic modeling of flurbiprofen, the active metabolite of flurbiprofen Axetil, in Chinese Patients with Postoperative Pain. J Pain Res. 2020;13:553. doi:10.2147/jpr.S251590
  • Tyagi P, Santos JL. Macromolecule nanotherapeutics: approaches and challenges. Drug Discov Today. 2018;23(5):1053–1061. doi:10.1016/j.drudis.2018.01.017
  • Er Y, Barnes TJ, Fornasiero D, et al. The encapsulation and release of guanosine from PEGylated liposomes. J Liposome Res. 2009;19(1):29–36. doi:10.1080/08982100802673940
  • Saneja A, Kumar R, Singh A, et al. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. Int J Pharm. 2017;531(1):153–166. doi:10.1016/j.ijpharm.2017.08.076
  • Usta A, Man KP, Strong N, et al. Investigating MTX-Loaded magnetic nanocomposite particles for treatment of rheumatoid arthritis. J Magn Magn Mater. 2020;499:166171. doi:10.1016/j.jmmm.2019.166171
  • Wu H, Su S, Wu Y, et al. Nanoparticle-facilitated delivery of BAFF-R siRNA for B cell intervention and rheumatoid arthritis therapy. Int Immunopharmacol. 2020;88:106933. doi:10.1016/j.intimp.2020.106933
  • Guo Y, Ye Q, Yang S, et al. Therapeutic effects of polysaccharides from Anoectochilus roxburghii on type II collagen-induced arthritis in rats. Int J Biol Macromol. 2019;122:882–892. doi:10.1016/j.ijbiomac.2018.11.015
  • Ma YX, Song YX, Ma F, et al. a potential polymeric nanogel system for effective delivery of chlorogenic acid to target collagen-induced arthritis. J Inorg Organomet Polym Mater. 2020;30(7):2356–2365. doi:10.1007/s10904-019-01421-8
  • Liang X, Chen X, Zhao G, et al. Preparation, characterization, and pharmacokinetic evaluation of imperatorin lipid microspheres and their effect on the proliferation of MDA-MB-231 Cells. Pharmaceutics. 2018;10(4):236. doi:10.3390/pharmaceutics10040236
  • Chen Z, Luo Z, Lyu J, et al. Preparation and formulation optimization of methotrexate-loaded human serum albumin nanoparticles modified by mannose. Curr Med Chem. 2021;28(24):5016–5029. doi:10.2174/0929867328666210118112640
  • Aktan B, Chambre L, Sanyal R, et al. “Clickable” nanogels via thermally driven self-assembly of polymers: facile access to targeted imaging platforms using thiol-maleimide conjugation. Biomacromolecules. 2017;18(2):490–497. doi:10.1021/acs.biomac.6b01576
  • Liu XY, Ruan LM, Mao WW, et al. Preparation of RGD-modified long circulating liposome loading matrine, and its in vitro anti-cancer effects. Int J Med Sci. 2010;7(4):197–208. doi:10.7150/ijms.7.197
  • Tizro P, Choi C, Khanlou N. sample preparation for transmission electron microscopy. Methods Mol Biol. 2019;1897:417–424. doi:10.1007/978-1-4939-8935-5_33
  • Huang X, Li Y, Fu M, Xin HB. Polarizing macrophages in vitro. Methods Mol Biol. 2018;1784:119–126. doi:10.1007/978-1-4939-7837-3_12
  • Hinz B, Brune K, Rau T, et al. Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages. Pharm Res. 2001;18(2):151–156. doi:10.1023/a:1011020132140
  • Boutet MA, Najm A, Bart G, et al. IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro. Ann Rheum Dis. 2017;76(7):1304–1312. doi:10.1136/annrheumdis-2016-210630
  • Wu J, Fan KJ, Wang QS, et al. DMY protects the knee joints of rats with collagen-induced arthritis by inhibition of NF-κB signaling and osteoclastic bone resorption. Food Funct. 2020;11(7):6251–6264. doi:10.1039/d0fo00396d
  • Wang Q, Jiang H, Li Y, et al. Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials. 2017;122:10–22. doi:10.1016/j.biomaterials.2017.01.008
  • Kubota A, Suguro T, Nakajima A, et al. Effect of biological agents on synovial tissues from patients with rheumatoid arthritis. Mod Rheumatol. 2020;30(2):282–286. doi:10.1080/14397595.2019.1583783
  • Luo S, Li H, Liu J, et al. Andrographolide ameliorates oxidative stress, inflammation and histological outcome in complete Freund’s adjuvant-induced arthritis. Chem Biol Interact. 2020;319:108984. doi:10.1016/j.cbi.2020.108984
  • Wang Y, Yan M, Zheng GY, et al. A cell-based, high-throughput homogeneous time-resolved fluorescence assay for the screening of potential κ-opioid receptor agonists. Acta Pharmacol Sin. 2014;35(7):957–966. doi:10.1038/aps.2014.21
  • Deng C, Zhang Q, He P, et al. Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis. Nat Commun. 2021;12(1):2174. doi:10.1038/s41467-021-22454-z
  • Maître JM, Boss G, Testa B. High-performance liquid chromatographic separation of the enantiomers of anti-inflammatory 2-arylpropionates: suitability of the method for in vitro metabolic studies. J Chromatogr. 1984;299(2):397–403. doi:10.1016/s0021-9673(01)97855-0
  • Huckaby JT, Jacobs TM, Li Z, et al. Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers. Commun Chem. 2020;3(1):124. doi:10.1038/s42004-020-00369-y
  • Sun Y, Kang C, Liu F, et al. RGD peptide-based target drug delivery of doxorubicin nanomedicine. Drug Dev Res. 2017;78(6):283–291. doi:10.1002/ddr.21399
  • Davies NM. Clinical pharmacokinetics of flurbiprofen and its enantiomers. Clin Pharmacokinet. 1995;28(2):100–114. doi:10.2165/00003088-199528020-00002